IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNγ

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Foucher, Etienne D ^a,b,c   Blanchard, Simon ^a,b,c   Preisser, Laurence ^a,b,c   Garo, Erwan ^a,b,c   Ifrah, Norbert ^a,b,c   Guardiola, Philippe ^a,b,c,d   Delneste, Yves ^a,b,c   Jeannin, Pascale ^a,b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b INSERM   (France)

^c CNRS   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 34; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; PHENOTYPIC PLASTICITY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CHEMOKINES; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKINS; MACROPHAGES; MONOCYTES; PHENOTYPE; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, CHEMOKINE;

EID: 84873659707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056045     Document Type: Article

References (39)

1. Narni-Mancinelli E, Soudja SM, Crozat K, Dalod M, Gounon P, et al. (2011) Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo. PLoS Pathog 7: e1002457.
2. Soudja SM, Ruiz AL, Marie JC, Lauvau G, (2012) Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549-562.
3. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nature reviews Immunology 5: 953-964.
4. Sica A, Mantovani A, (2012) Macrophage plasticity and polarization: in vivo veritas. The Journal of clinical investigation 122: 787-795.
5. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature immunology 11: 889-896.
6. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends in immunology 25: 677-686.
7. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proceedings of the National Academy of Sciences of the United States of America 101: 4560-4565.
8. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, et al. (2012) Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models. Journal of immunology 188: 5752-5765.
9. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD, (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. Journal of immunology 178: 5245-5252.
10. Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, et al. (2007) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110: 4319-4330.
11. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nature reviews Immunology 8: 958-969.
12. Lin H, Lee E, Hestir K, Leo C, Huang M, et al. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320: 807-811.
13. Chihara T, Suzu S, Hassan R, Chutiwitoonchai N, Hiyoshi M, et al. (2010) IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell death and differentiation 17: 1917-1927.
14. Pandit J, Bohm A, Jancarik J, Halenbeck R, Koths K, et al. (1992) Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 258: 1358-1362.
15. Droin N, Solary E, (2010) Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebrates. Journal of leukocyte biology 87: 745-747.
16. Ma X, Lin WY, Chen Y, Stawicki S, Mukhyala K, et al. (2012) Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 20: 676-687.
17. Wei S, Nandi S, Chitu V, Yeung YG, Yu W, et al. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. Journal of leukocyte biology 88: 495-505.
18. Nandi S, Gokhan S, Dai XM, Wei S, Enikolopov G, et al. (2012) The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Developmental biology.
19. Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, et al. (2012) Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 37: 1050-1060.
20. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, et al. (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature immunology 13: 753-760.
21. Chen Z, Buki K, Vaaraniemi J, Gu G, Vaananen HK, (2011) The critical role of IL-34 in osteoclastogenesis. PloS one 6: e18689.
22. Baud'huin M, Renault R, Charrier C, Riet A, Moreau A, et al. (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. The Journal of pathology 221: 77-86.
23. Chemel M, Le Goff B, Brion R, Cozic C, Berreur M, et al. (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 71: 150-154.
24. Hwang SJ, Choi B, Kang SS, Chang JH, Kim YG, et al. (2012) Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res Ther 14: R14.
25. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, et al. (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1: 54-67.
26. Metcalf D, (1991) Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254: 529-533.
27. Gliniak BC, Park LS, Rohrschneider LR, (1992) A GM-colony-stimulating factor (CSF) activated ribonuclease system transregulates M-CSF receptor expression in the murine FDC-P1/MAC myeloid cell line. Molecular biology of the cell 3: 535-544.
28. Jeannin P, Duluc D, Delneste Y, (2011) IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-gamma. Immunotherapy 3: 23-26.
29. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, et al. (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. The Journal of clinical investigation 107: 1173-1181.
30. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of immunology 177: 7303-7311.
31. Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, et al. (2012) High-resolution transcriptome of human macrophages. PloS one 7: e45466.
32. Gliniak BC, Rohrschneider LR, (1990) Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF. Cell 63: 1073-1083.
33. Sica A, Schioppa T, Mantovani A, Allavena P, (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. European journal of cancer 42: 717-727.
34. Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, et al. (2009) Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. International journal of cancer Journal international du cancer 125: 367-373.
35. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, et al. (1994) Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120: 1357-1372.
36. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, et al. (2006) Langerhans cells arise from monocytes in vivo. Nature immunology 7: 265-273.
37. Mizuno T, Doi Y, Mizoguchi H, Jin S, Noda M, et al. (2011) Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-beta neurotoxicity. The American journal of pathology 179: 2016-2027.
38. Brocheriou I, Maouche S, Durand H, Braunersreuther V, Le Naour G, et al. (2011) Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 214: 316-324.
39. Espinoza-Delgado I, Longo DL, Gusella GL, Varesio L, (1990) IL-2 enhances c-fms expression in human monocytes. Journal of immunology 145: 1137-1143.